Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0098 | 0.9 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |